Kuo Chuan Tsai
Chief Executive Officer chez SYNEURX INTERNATIONAL (TAIWAN) CORP.
Profil
Kuo Chuan Tsai is the founder and Chief Executive Officer of SyneuRx International (Taiwan) Corp., which was founded in 2013.
He is currently a Professor at the University of California.
Dr. Tsai holds a doctorate degree from The Johns Hopkins University, an undergraduate degree from National Yang Ming University, and an MBA from Carey Business School.
Postes actifs de Kuo Chuan Tsai
| Sociétés | Poste | Début |
|---|---|---|
| SYNEURX INTERNATIONAL (TAIWAN) CORP. | Chief Executive Officer | 10/07/2013 |
| University of California | Corporate Officer/Principal | - |
Formation de Kuo Chuan Tsai
| The Johns Hopkins University | Doctorate Degree |
| National Yang Ming University | Undergraduate Degree |
| Carey Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
SyneuRx International (Taiwan) Corp.
 SyneuRx International (Taiwan) Corp. BiotechnologyHealth Technology SyneuRx International (Taiwan) Corp. engages in the manufacture and sale of medicines. It offers different kinds of medicines, which are useful for brain disorders like schizophrenia have largely failed to materialize and mental illnesses like depression, obsessive compulsive disorder, attention deficit hyperactivity disorder, autism and dementia. The company was founded by Kuo Chuan Tsai on April 2, 2013 and is headquartered in New Taipei, Taiwan. | Health Technology |
